BMC Infectious Diseases

official impact factor 2.83

Open Access

Ofloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]

Oguz Karabay*, Irfan Sencan, Derya Kayas and Idris Şahin

BMC Infectious Diseases 2004, 4:18 doi:10.1186/1471-2334-4-18

Accesses  

  • Last 30 days: 59 accesses
  • Last 365 days: 705 accesses
  • All time: 7108 accesses

Cited by